Principal Street Partners LLC Trims Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Principal Street Partners LLC trimmed its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 7.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,644 shares of the medical research company’s stock after selling 207 shares during the period. Principal Street Partners LLC’s holdings in IQVIA were worth $625,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of IQV. Advisors Asset Management Inc. increased its position in IQVIA by 106.4% during the 1st quarter. Advisors Asset Management Inc. now owns 1,298 shares of the medical research company’s stock worth $328,000 after purchasing an additional 669 shares in the last quarter. Caxton Associates LP purchased a new position in shares of IQVIA during the 1st quarter worth about $842,000. B. Riley Wealth Advisors Inc. grew its holdings in IQVIA by 13.9% in the first quarter. B. Riley Wealth Advisors Inc. now owns 3,568 shares of the medical research company’s stock valued at $902,000 after purchasing an additional 436 shares during the period. Meiji Yasuda Life Insurance Co raised its stake in IQVIA by 24.0% during the first quarter. Meiji Yasuda Life Insurance Co now owns 1,810 shares of the medical research company’s stock worth $458,000 after purchasing an additional 350 shares during the period. Finally, California State Teachers Retirement System boosted its holdings in shares of IQVIA by 1.2% in the 1st quarter. California State Teachers Retirement System now owns 300,804 shares of the medical research company’s stock valued at $76,070,000 after purchasing an additional 3,663 shares during the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

IQVIA Stock Down 1.4 %

Shares of NYSE IQV traded down $2.79 during midday trading on Tuesday, reaching $201.23. 24,746 shares of the company’s stock were exchanged, compared to its average volume of 1,173,094. The stock has a market capitalization of $36.52 billion, a PE ratio of 26.77, a price-to-earnings-growth ratio of 2.08 and a beta of 1.51. IQVIA Holdings Inc. has a 52-week low of $187.62 and a 52-week high of $261.73. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The business’s fifty day moving average price is $221.96 and its two-hundred day moving average price is $226.98.

Analyst Ratings Changes

A number of analysts have recently commented on IQV shares. Truist Financial dropped their price objective on IQVIA from $286.00 to $265.00 and set a “buy” rating for the company in a report on Monday, November 4th. Morgan Stanley cut their price objective on IQVIA from $280.00 to $265.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Barclays decreased their target price on IQVIA from $260.00 to $255.00 and set an “overweight” rating for the company in a report on Friday, November 1st. Robert W. Baird cut their price target on shares of IQVIA from $256.00 to $223.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Finally, Leerink Partners reiterated an “outperform” rating and set a $248.00 price objective (down from $260.00) on shares of IQVIA in a research note on Tuesday, November 19th. Four investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.